Applied DNA Sciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $304 | $983 | $1,196 | $813 |
Gross Profit | 5 | 370 | 684 | 244 |
EBITDA | -3,615 | -3,343 | -2,905 | -3,194 |
EBIT | -3,694 | -3,461 | -2,964 | -3,271 |
Net Income | -3,945 | -3,304 | -2,639 | -3,296 |
Net Change In Cash | 304 | 983 | 1,196 | 813 |
Free Cash Flow | -2,827 | -3,370 | -3,442 | -3,620 |
Cash | 4,727 | 6,823 | 9,294 | 6,431 |
Basic Shares | 572 | 118 | 42 | 13 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $3,431 | $13,367 | $18,168 | $9,027 |
Gross Profit | 1,016 | 5,533 | 5,053 | 4,482 |
EBITDA | -13,328 | -9,591 | -12,679 | -11,682 |
EBIT | -14,024 | -10,953 | -13,969 | -12,526 |
Net Income | -6,992 | -9,947 | -8,267 | -14,286 |
Net Change In Cash | 3,431 | 13,367 | 18,168 | 9,027 |
Free Cash Flow | -14,119 | -6,296 | -9,466 | -15,936 |
Cash | 6,431 | 7,151 | 15,215 | 6,554 |
Basic Shares | 105 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$33.99 |
2025-03-31 | -$230.30 |
2024-12-31 | -$417.52 |
2024-09-30 | -$240.01 |
